Severe familial left ventricular non-compaction cardiomyopathy due to a novel troponin T (TNNT2) mutation

Cardiovascular Research

Volumn 86, Issue 3, 2010, Pages 452-460

  Luedde, Mark ^a   Ehlermann, Philipp ^a   Weichenhan, Dieter ^a   Will, Rainer ^a   Zeller, Raphael ^a   Rupp, Stefan ^b   Müller, Andreas ^a   Steen, Henning ^a   Ivandic, Boris T ^a   Ulmer, Herbert E ^a   Kern, Michael ^a   Katus, Hugo A ^a   Frey, Norbert ^c  

^a UNIVERSITY OF HEIDELBERG   (Germany)

^b JUSTUS LIEBIG UNIVERSITY   (Germany)

^c UNIVERSITY OF KIEL   (Germany)

Author keywords

Cardiomyopathy; Left ventricular non compaction; Mutation; Transgenic animal model; Troponin T

Indexed keywords

BETA ADRENERGIC RECEPTOR BLOCKING AGENT; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; DIURETIC AGENT; TNNT2 PROTEIN; TROPONIN T; UNCLASSIFIED DRUG;

ADULT; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CASE REPORT; CAUCASIAN; CAUSE OF DEATH; COLOR ULTRASOUND FLOWMETRY; CONGESTIVE CARDIOMYOPATHY; CONGESTIVE HEART FAILURE; CONTROLLED STUDY; DISEASE COURSE; DYSPNEA; ECHOCARDIOGRAPHY; EXERCISE; EXPLANT; FAMILIAL LEFT VENTRICULAR NONCOMPACTION CARDIOMYOPATHY; FAMILY; FAMILY HISTORY; FATHER; FEMALE; GENE EXPRESSION; GENETIC ASSOCIATION; GENETIC SCREENING; HEART CATHETERIZATION; HEART FAILURE; HEART LEFT VENTRICLE ENDDIASTOLIC PRESSURE; HEART LEFT VENTRICLE FAILURE; HEART LEFT VENTRICLE WALL; HEART MUSCLE; HEART MUSCLE FIBROSIS; HEART TRANSPLANTATION; HISTOLOGY; HUMAN; HUMAN TISSUE; HYPOKINESIA; INFANT; MALE; MARKER GENE; MISSENSE MUTATION; MOUSE; MUTATIONAL ANALYSIS; NONHUMAN; NUCLEAR MAGNETIC RESONANCE IMAGING; PATHOPHYSIOLOGY; PHENOTYPE; PRIORITY JOURNAL; PROGENY; RELATIVE; TISSUE SECTION; TRANSGENIC MOUSE; WILD TYPE;

ANIMALS; BIOPSY; CASE-CONTROL STUDIES; DNA MUTATIONAL ANALYSIS; ECHOCARDIOGRAPHY, DOPPLER, COLOR; EXONS; FEMALE; GENETIC PREDISPOSITION TO DISEASE; HUMANS; INFANT; ISOLATED NONCOMPACTION OF THE VENTRICULAR MYOCARDIUM; MAGNETIC RESONANCE IMAGING, CINE; MALE; MICE; MICE, INBRED C57BL; MICE, TRANSGENIC; MIDDLE AGED; MUTATION, MISSENSE; MYOCARDIAL CONTRACTION; PEDIGREE; PHENOTYPE; SEVERITY OF ILLNESS INDEX; STROKE VOLUME; TROPONIN T; VENTRICULAR DYSFUNCTION, LEFT; YOUNG ADULT;

EID: 77951557843     PISSN: 00086363     EISSN: 17553245     Source Type: Journal    
DOI: 10.1093/cvr/cvq009     Document Type: Article

References (40)

1. Weiford BC, Subbarao VD, Mulhern KM. Noncompaction of the ventricular myocardium. Circulation 2004;109:2965-2971.
2. Chin TK, Perloff JK, Williams RG, Jue K, Mohrmann R. Isolated noncompaction of left ventricular myocardium. A study of eight cases. Circulation 1990;82:507-513.
3. Hoedemaekers YM, Caliskan K, Majoor-Krakauer D, van de Laar I, Michels M, Witsenburg M et al. Cardiac fbetag-myosin heavy chain defects in two families with non-compaction cardiomyopathy: linking non-compaction to hypertrophic, restrictive, and dilated cardiomyopathies. Eur Heart J 2007;28:2732-2737.
4. Kaneda T, Naruse C, Kawashima A, Fujino N, Oshima T, Namura M et al. A novel beta-myosin heavy chain gene mutation, p.Met531Arg, identified in isolated left ventricular noncompaction in humans, resulted in left ventricular hypertrophy that progressed to dilation in a mouse model. Clin Sci 2007;23:23.
5. Klaassen S, Probst S, Oechslin E, Gerull B, Krings G, Schuler P et al. Mutations in sar-comere protein genes in left ventricular noncompaction. Circulation 2008;117: 2893-2901.
6. Monserrat L, Hermida-Prieto M, Fernandez X, Rodriguez I, Dumont C, Cazon L et al. Mutation in the alpha-cardiac actin gene associated with apical hypertrophic cardio-myopathy, left ventricular non-compaction, and septal defects. Eur Heart J 2007;28: 1953-1961.
7. Murphy RT, Thaman R, Blanes JG, Ward D, Sevdalis E, Papra E et al. Natural history and familial characteristics of isolated left ventricular non-compaction. Eur Heart J 2005;26:187-192. (Pubitemid 40282788)
8. Pignatelli RH, McMahon CJ, Dreyer WJ, Denfield SW, Price J, Belmont JW et al. Clinical characterization of left ventricular noncompaction in children: a relatively common form of cardiomyopathy. Circulation 2003;108:2672-2678.
9. Bione S, D'Adamo P, Maestrini E, Gedeon AK, Bolhuis PA, Toniolo D. A novel X-linked gene, G4.5. is responsible for Barth syndrome. Nat Genet 1996;12:385-389.
10. Bleyl SB, Mumford BR, Thompson V, Carey JC, Pysher TJ, Chin TK et al. Neonatal, lethal noncompaction of the left ventricular myocardium is allelic with Barth syndrome. Am J Hum Genet 1997;61:868-872.
11. Sen-Chowdhry S, McKenna WJ. Left ventricular noncompaction and cardiomyopathy: cause, contributor, or epiphenomenon? Curr Opin Cardiol 2008;23:171-175.
12. Oechslin EN, Attenhofer Jost CH, Rojas JR, Kaufmann PA, Jenni R. Long-term follow-up of 34 adults with isolated left ventricular noncompaction: a distinct cardi-omyopathy with poor prognosis. J Am Coll Cardiol 2000;36:493-500.
13. Ichida F, Hamamichi Y, Miyawaki T, Ono Y, Kamiya T, Akagi T et al. Clinical features of isolated noncompaction of the ventricular myocardium: long-term clinical course, hemodynamic properties, and genetic background. J Am Coll Cardiol 1999;34: 233-240.
14. Ichida F, Tsubata S, Bowles KR, Haneda N, Uese K, Miyawaki T et al. Novel gene mutations in patients with left ventricular noncompaction or Barth syndrome. Circulation 2001;103:1256-1263.
15. Vatta M, Mohapatra B, Jimenez S, Sanchez X, Faulkner G, Perles Z et al. Mutations in Cypher/ZASP in patients with dilated cardiomyopathy and left ventricular non-compaction. J Am Coll Cardiol 2003;42:2014-2027.
16. Hermida-Prieto M, Monserrat L, Castro-Beiras A, Laredo R, Soler R, Peteiro J et al. Familial dilated cardiomyopathy and isolated left ventricular noncompaction associated with lamin A/C gene mutations. Am J Cardiol 2004;94:50-54.
17. Budde BS, Binner P, Waldmuller S, Hohne W, Blankenfeldt W, Hassfeld S et al. Non-compaction of the ventricular myocardium is associated with a de novo mutation in the beta-myosin heavy chain gene. PLoS ONE 2007;2:e1362.
18. Mogensen J, Murphy RT, Shaw T, Bahl A, Redwood C, Watkins H et al. Severe disease expression of cardiac troponin C and T mutations in patients with idiopathic dilated cardiomyopathy. J Am Coll Cardiol 2004;44:2033-2040.
19. Luedde M, Flogel U, Knorr M, Grundt C, Hippe HJ, Brors B et al. Decreased contractility due to energy deprivation in a transgenic rat model of hypertrophic cardiomyo-pathy. J Mol Med 2009;87:411-422.
20. Maron BJ, Towbin JA, Thiene G, Antzelevitch C, Corrado D, Arnett D et al. Contemporary definitions and classification of the cardiomyopathies: an American Heart Association Scientific Statement from the Council on Clinical Cardiology, Heart Failure and Transplantation Committee; Quality of Care and Outcomes Research and Functional Genomics and Translational Biology Interdisciplinary Working Groups; and Council on Epidemiology and Prevention. Circulation 2006;113: 1807-1816.
21. Mestroni L, Maisch B, McKenna WJ, Schwartz K, Charron P, Rocco C et al. Guidelines for the study of familial dilated cardiomyopathies. Collaborative Research Group of the European Human and Capital Mobility Project on Familial Dilated Cardiomyopa-thy. Eur Heart J 1999;20:93-102.
22. Jenni R, Oechslin E, Schneider J, Attenhofer Jost C, Kaufmann PA. Echocardiographic and pathoanatomical characteristics of isolated left ventricular non-compaction: a step towards classification as a distinct cardiomyopathy. Heart 2001;86:666-671.
23. Jenni R, Oechslin EN, van der Loo B. Isolated ventricular non-compaction of the myocardium in adults. Heart 2007;93:11-15.
24. Petersen SE, Selvanayagam JB, Wiesmann F, Robson MD, Francis JM, Anderson RH et al. Left ventricular non-compaction: insights from cardiovascular magnetic resonance imaging. J Am Coll Cardiol 2005;46:101-105.
25. Zeller R, Ivandic BT, Ehlermann P, Mucke O, Zugck C, Remppis A et al. Large-scale mutation screening in patients with dilated or hypertrophic cardiomyopathy: a pilot study using DGGE. J Mol Med 2006;20:20.
26. Nicol RL, Frey N, Pearson G, Cobb M, Richardson J, Olson EN. Activated MEK5 induces serial assembly of sarcomeres and eccentric cardiac hypertrophy. EMBO J 2001;20:2757-2767.
27. Peddy SB, Vricella LA, Crosson JE, Oswald GL, Cohn RD, Cameron DE et al. Infantile restrictive cardiomyopathy resulting from a mutation in the cardiac troponin T gene. Pediatrics 2006;117:1830-1833.
28. Palm T, Graboski S, Hitchcock-DeGregori SE, Greenfield NJ. Disease-causing mutations in cardiac troponin T: identification of a critical tropomyosin-binding region. Biophys J 2001;81:2827-2837.
29. Pinto JR, Parvatiyar MS, Jones MA, Liang J, Potter JD. A troponin T mutation that causes infantile restrictive cardiomyopathy increases Ca2\+ sensitivity of force development and impairs the inhibitory properties of troponin. J Biol Chem 2008;283: 2156-2166.
30. Ertz-Berger BR, He H, Dowell C, Factor SM, Haim TE, Nunez S et al. Changes in the chemical and dynamic properties of cardiac troponin T cause discrete cardiomyopa-thies in transgenic mice. Proc Natl Acad Sci USA 2005;102:18219-18224.
31. Dellefave L, McNally EM. Sarcomere mutations in cardiomyopathy, noncompaction, and the developing heart. Circulation 2008;117:2847-2849.
32. Konhilas JP, Watson PA, Maass A, Boucek DM, Horn T, Stauffer BL et al. Exercise can prevent and reverse the severity of hypertrophic cardiomyopathy. Circ Res 2006;98: 540-548.
33. Richard P, Charron P, Carrier L, Ledeuil C, Cheav T, Pichereau C et al. Hypertrophic cardiomyopathy: distribution of disease genes, spectrum of mutations, and implications for a molecular diagnosis strategy. Circulation 2003;107:2227-2232.
34. Marian AJ. Modifier genes for hypertrophic cardiomyopathy. Curr Opin Cardiol 2002; 17:242-252.
35. Semsarian C, Healey MJ, Fatkin D, Giewat M, Duffy C, Seidman CE et al. A polymorphic modifier gene alters the hypertrophic response in a murine model of familial hypertrophic cardiomyopathy. J Mol Cell Cardiol 2001;33:2055-2060.
36. Nishii K, Morimoto S, Minakami R, Miyano Y, Hashizume K, Ohta M et al. Targeted disruption of the cardiac troponin T gene causes sarcomere disassembly and defects in heartbeat within the early mouse embryo. Dev Biol 2008;322:65-73.
37. Ahmad F, Banerjee SK, Lage ML, Huang XN, Smith SH, Saba S et al. The role of cardiac troponin T quantity and function in cardiac development and dilated cardio-myopathy. PLoS ONE 2008;3:e2642.
38. Robinson P, Mirza M, Knott A, Abdulrazzak H, Willott R, Marston S et al. Alterations in thin filament regulation induced by a human cardiac troponin T mutant that causes dilated cardiomyopathy are distinct from those induced by troponin T mutants that cause hypertrophic cardiomyopathy. J Biol Chem 2002;277:40710-40716.
39. Biagini E, Ragni L, Ferlito M, Pasquale F, Lofiego C, Leone O et al. Different types of cardiomyopathy associated with isolated ventricular noncompaction. Am J Cardiol 2006;98:821-824.
40. Henry WL, Gardin JM, Ware JH. Echocardiographic measurements in normal subjects from infancy to old age. Circulation 1980;62:1054-1061.